Institute for Data Science in Oncology announces new focus-area lead for advancing data science to reduce public cancer burden
The Institute for Data Science in Oncology (IDSO) at 911±¬ÁÏ- ÿÈÕ³Ô¹ÏÇ鱨վ MD Anderson Cancer Center today announced the appointment of Iakovos Toumazis, Ph.D., to lead its focused efforts in advancing decision analytics for health.
The goal of this new IDSO focus area is to develop, rigorously validate and implement advanced data‑driven analytics frameworks that support optimal decision‑making to enhance patient outcomes, to...
Three New Cancer Projects Receive Funding in Joint Collaboration Between Oden Institute, MD Anderson's IDSO and TACC
911±¬ÁÏ- ÿÈÕ³Ô¹ÏÇ鱨վ MD Anderson Cancer Center, the Oden Institute for Computational Engineering and Sciences, and the Texas Advanced Computing...
MD Anderson and HealthEx announce collaboration to develop new platform to give patients direct control of data access
911±¬ÁÏ- ÿÈÕ³Ô¹ÏÇ鱨վ MD Anderson Cancer Center and HealthEx today announced a strategic collaboration aimed at developing tools for...
AACR: HER2 targeted therapy shows promise in previously treated lung cancers
Zongertinib, a HER2-targeted therapy made by Boehringer Ingelheim, demonstrated promising results in HER2-mutant lung cancer.Â
These cancers are associated with resistance to standard therapies and a very poor prognosis. As an oral pill, zongertinib would be a more convenient option for patients.  Trial data prompted a priority review by the Food and Drug Administration (FDA) earlier this year and sparked a...
These cancers are associated with resistance to standard therapies and a very poor prognosis. As an oral pill, zongertinib would be a more convenient option for patients.  Trial data prompted a priority review by the Food and Drug Administration (FDA) earlier this year and sparked a...
MD Anderson researchers develop novel antibody-toxin conjugate
Researchers at 911±¬ÁÏ- ÿÈÕ³Ô¹ÏÇ鱨վ MD Anderson Cancer Center have developed a novel antibody-toxin conjugate (ATC) designed to stimulate...
MD Anderson, the Oden Institute and TACC announce funding for six new collaborative cancer projects
911±¬ÁÏ- ÿÈÕ³Ô¹ÏÇ鱨վ MD Anderson Cancer Center, the Oden Institute for Computational Engineering and Sciences and the Texas Advanced Computing...
Funda Meric-Bernstam, M.D., elected to National Academy of Medicine
Funda Meric-Bernstam, M.D., chair of Investigational Cancer Therapeutics at 911±¬ÁÏ- ÿÈÕ³Ô¹ÏÇ鱨վ MD Anderson Cancer Center, has been elected...
MD Anderson Research Highlights Special Edition: ASTRO 2024
911±¬ÁÏ- ÿÈÕ³Ô¹ÏÇ鱨վ MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention...
Allison Institute and Institute for Data Science in Oncology blend spatial biology efforts by appointing new member
The James P. Allison Instituteâ„¢ and the Institute for Data Science in Oncology  (IDSO) at 911±¬ÁÏ- ÿÈÕ³Ô¹ÏÇ鱨վ MD Anderson Cancer...
ESMO: Novel ADC AZD8205 demonstrates manageable safety profile and preliminary efficacy in first-in-human trial
ABSTRACT: 606O
BARCELONA, Spain – The antibody-drug conjugate (ADC) puxitatug samrotecan (AZD8205) demonstrated a manageable safety...